Correcting Defective Genes to cure genetic disease
Successful gene therapy approaches necessitate exact gene delivery and expression control, suited to the highly complex in vivo environment of clinical applications. By serving the entire AAV value-chain SIRION BIOTECH is the gateway to fast clinical vectors.
SIRION BIOTECH keys to success:
- Vector evolution and engineering
- Established manufacturing processes, from R&D into clinic
- Strong client commitment with designated contact managers
- Streamlined communication through strategic partnerships with academic & CDMO partners
- Seamless process transfers
AAV engineering - optimize for clinical trials
AAV Manufacture - be GMP-ready
LentiTHERAPY™ - cell specific transduction technology
Contact us – discover how SIRION can excel to your therapeutic R&D.